Omega-3 fatty acids in primary and secondary prevention of cardiovascular diseases

被引:7
作者
Tutor, Austin [1 ]
O'Keefe, Evan L. [2 ,3 ]
Lavie, Carl J. [1 ]
Elagizi, Andrew [4 ]
Milani, Richard [5 ]
O'Keefe, James [2 ,3 ]
机构
[1] Univ Queensland, John Ochsner Heart & Vasc Inst, Ochsner Clin Sch, Dept Cardiovasc Dis,Sch Med, New Orleans, LA USA
[2] St Lukes Mid Amer Heart Inst, Kansas City, MO USA
[3] Univ Missouri Kansas City, Kansas City, MO USA
[4] Southlake Reg Hlth Ctr, Dept Cardiovasc Dis, 596 Davis Dr, Newmarket, ON L3Y 2P9, Canada
[5] Pier One, Sutter Hlth, Ctr Clin Innovat, Bay 1A, San Francisco, CA 94111 USA
关键词
Omega-3 polyunsaturated fatty acids; Fish oil; Cardiovascular disease; Myocardial infarction; POLYUNSATURATED FATTY-ACIDS; FISH CONSUMPTION; EICOSAPENTAENOIC ACID; HEART-FAILURE; HYPERCHOLESTEROLEMIC PATIENTS; RISK; SUPPLEMENTATION; MORTALITY; EVENTS; STROKE;
D O I
10.1016/j.pcad.2024.03.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Even with substantial progress in primary and secondary prevention, cardiovascular disease (CVD) persists as a major cause of mortality and morbidity globally. Omega-3 polyunsaturated fatty acids (Omega-3 PUFAs) have gained considerable attention for their ability to improve CV health and prognosis. Metanalyses of randomized controlled trials have demonstrated Omega-3 PUFAs' positive impact on CVD outcomes for both primary and secondary prevention endpoints. Marine Omega-3 PUFAs also improve CVD risk factors including blood pressure, lipids, and inflammation; however, many physicians do not recommend Omega-3 PUFAs, largely due to inconsistent results in randomized trials. In this comprehensive review article, we evaluate both historic and current data concerning primary and secondary prevention of CVD with use of Omega-3 PUFAs, delve into the potential causes for the varied results, and examine the most current recommendations on the usage of Omega-3 PUFAs.
引用
收藏
页码:19 / 26
页数:8
相关论文
共 50 条
[41]   Cardiovascular effects of marine omega-3 fatty acids [J].
Saravanan, Palaniappan ;
Davidson, Neil C. ;
Schmidt, Erik B. ;
Calder, Philip C. .
LANCET, 2010, 376 (9740) :540-550
[42]   Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, double blind, placebo controlled trials [J].
Casula, Manuela ;
Soranna, Davide ;
Catapano, Alberico L. ;
Corrao, Giovanni .
ATHEROSCLEROSIS SUPPLEMENTS, 2013, 14 (02) :243-251
[43]   Hypertriglyceridemia and omega-3 fatty acids: Their often overlooked role in cardiovascular disease prevention [J].
Arca, M. ;
Borghi, C. ;
Pontremoli, R. ;
De Ferrari, G. M. ;
Colivicchi, F. ;
Desideri, G. ;
Temporelli, P. L. .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2018, 28 (03) :197-205
[44]   Current state-of-the-art knowledge on the role of omega-3 fatty acids in the prevention of cardiovascular disease [J].
Klosiewicz-Latoszek, Longina ;
Cybulska, Barbara ;
Tyszko, Piotr .
ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2020, 27 (04) :519-525
[45]   Omega-3 Fatty Acids and Cardiovascular Disease: New Developments and Applications [J].
Harris, William S. ;
Dayspring, Thomas D. ;
Moran, Terrance J. .
POSTGRADUATE MEDICINE, 2013, 125 (06) :100-113
[46]   Omega-3 fatty acids in the prevention and control of cardiovascular disease [J].
P Mata López ;
R M Ortega .
European Journal of Clinical Nutrition, 2003, 57 :S22-S25
[47]   Omega-3 fatty acids in the prevention and control of cardiovascular disease [J].
López, PM ;
Ortega, RM .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2003, 57 (Suppl 1) :S22-S25
[48]   The Effect of Omega-3 Fatty Acids on Insulin Resistance [J].
Sinha, Susmita ;
Haque, Mainul ;
Lugova, Halyna ;
Kumar, Santosh .
LIFE-BASEL, 2023, 13 (06)
[49]   Omega-3 fatty acids for the treatment of elevated triglycerides [J].
Maki, Kevin C. ;
Dicklin, Mary R. ;
Lawless, Andrea ;
Reeves, Matthew S. .
CLINICAL LIPIDOLOGY, 2009, 4 (04) :425-437
[50]   Microbiota, a New Playground for the Omega-3 Polyunsaturated Fatty Acids in Cardiovascular Diseases [J].
Rousseau, Guy .
MARINE DRUGS, 2021, 19 (02)